Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Racura Oncology Ltd
Impressive 40% response in Phase II Bisantrene AML Trial
Published Jun 16 2020
4 min read

Impressive 40% response in Phase II Bisantrene AML Trial

news images

Racura Oncology Ltd has released a press release.

View Attachment